SARS-CoV-2及非SARS-CoV-2疫苗接种后自身免疫性溶血性贫血与免疫性血小板减少症:32年被动监测数据
本研究回顾美国CDC疫苗不良事件报告系统(VAERS)1990至2022年数据,分析非SARS-CoV-2疫苗与SARS-CoV-2疫苗接种后自身免疫性溶血性贫血(AIHA)和免疫性血小板减少症(ITP)的报告特征。共发现863例报告,两组报告率均低,ITP最常见,非SARS-CoV-2组中麻疹-腮腺炎-风疹(MMR)疫苗接种后ITP报告显著更多(p < 0.001)。SARS-CoV-2疫苗组AIHA和ITP病例数更高,但仍非常罕见;被动报告显示免疫后自身免疫性血液病极罕见,且报告率低于一般人群。
要点
- 1990至2022年VAERS数据库共发现863例疫苗接种后AIHA和ITP报告。
- 两组中ITP报告均最常见;非SARS-CoV-2组MMR疫苗接种后ITP报告显著更多(p < 0.001)。
- SARS-CoV-2疫苗组AIHA和ITP病例数高于非SARS-CoV-2组,但总体上仍非常罕见。
核心结论
- 免疫接种后自身免疫性血液病极罕见,被动报告显示其报告率低于一般人群。
研究设计与样本
- 回顾性分析美国CDC VAERS数据库1990至2022年报告,比较非SARS-CoV-2疫苗与SARS-CoV-2疫苗接种后AIHA和ITP的报告。
主要发现
- 共发现863例疫苗接种后AIHA和ITP报告,涉及15种非SARS-CoV-2疫苗和4种SARS-CoV-2疫苗。
- 两组AIHA和ITP报告率均低,很大比例因缺乏临床细节被排除。
- 两组中ITP报告均最常见,非SARS-CoV-2组中MMR疫苗接种后ITP报告显著更多(p < 0.001)。
- SARS-CoV-2疫苗组AIHA和ITP病例数高于非SARS-CoV-2组,但最终仍非常罕见。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Autoimmune haemolytic anaemia (AIHA) and immune thrombocytopenia (ITP) are two uncommon haematologic autoimmune conditions that can rarely arise secondary to vaccination. Prior studies using the US Centers for Disease Control's (CDC) Vaccine Adverse Event Reporting System (VAERS) have demonstrated this infrequency, but contemporary data as well as comparison with current information regarding SARS-CoV-2 vaccination has not been assessed. In this study, we reviewed VAERS database reports from 1990 to 2022 to characterize the incidence and clinical and laboratory findings of non-SARS-CoV-2-associated AIHA and ITP and SARS-CoV-2 vaccine-associated AIHA and ITP. We discovered a total of 863 AIHA and ITP reports following vaccination with 15 non-SARS-CoV-2 and four SARS-CoV-2 vaccines submitted to the CDC VAERS database. AIHA and ITP reporting was low for both groups, with a large proportion excluded due to a lack of clinical details. ITP was reported the most frequently in both groups and was significantly more common with measles-mumps-rubella (MMR) vaccination (p < 0.001) in the non-SARS-CoV-2 group. AIHA and ITP cases were higher in the SARS-CoV-2 vaccine group, though ultimately still very infrequent. Autoimmune haematologic disease is vanishingly rare after immunization and rates are lower than in the general population according to passive reporting.
引用
- Jacobs JW, Booth GS, Guarente J, et al. Autoimmune haemolytic anaemia and immune thrombocytopenia following SARS-CoV-2 and non-SARS-CoV-2 vaccination: 32 Years of passive surveillance data. Br J Haematol. 2022. PMID: 36564040. doi:10.1111/bjh.18627
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。